Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 7Leukemia, Myeloid, Acute 5Recurrence 4Hepatitis C, Chronic 4Hepatitis C 4Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Respiratory Tract Infections 2Lymphoma, Mantle-Cell 2Infections 2Head and Neck Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Seminoma 1Respiratory Syncytial Virus Infections 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Neuroblastoma 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant Solid Tumor 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Ribavirin 2tocilizumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Respiratory Tract Infections × Ribavirin × Clear all
NCT01502072 2021-02-15

Respiratory Syncytial Virus - RSV Protocol

M.D. Anderson Cancer Center

Phase 2 Completed
48 enrolled 11 charts

Neoplasms, Pneumonia, Respiratory Tract Infections, Respiratory Syncytial Virus Infections

NCT00500578 2012-08-01

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

M.D. Anderson Cancer Center

Phase 4 Completed
51 enrolled 8 charts
Other hematologic neoplasm

Respiratory Tract Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡